Page last updated: 2024-09-02

fingolimod hydrochloride and Dyskinesia Syndromes

fingolimod hydrochloride has been researched along with Dyskinesia Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armida, M; De Simone, R; Mazziotti, V; Minghetti, L; Pèzzola, A; Popoli, P; Potenza, RL	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Dyskinesia Syndromes

Article	Year
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2016, Volume: 13, Issue:4 Topics: Amyotrophic Lateral Sclerosis; Animals; Body Weight; Brain; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mutation; Nitric Oxide Synthase Type II; Spinal Cord; Superoxide Dismutase	2016

Article

Year

Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2016, Volume: 13, Issue:4

Topics: Amyotrophic Lateral Sclerosis; Animals; Body Weight; Brain; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mutation; Nitric Oxide Synthase Type II; Spinal Cord; Superoxide Dismutase

2016